Forte Biosciences (FBRX) EBT Margin (2017 - 2019)
Forte Biosciences (FBRX) reported EBT Margin of 117588.89% for Q4 2019, up 9812222.0% year-over-year from N/an in Q4 2018, and up 43.51% quarter-over-quarter from 208166.67% in Q3 2019.
Forte Biosciences (FBRX) EBT Margin (2017 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has 3 years of EBT Margin data on file, last reported at 117588.89% in Q4 2019.
- EBT Margin for Q4 2019 came in at 117588.89%, up 9812222.0% year-over-year; the trailing twelve-month figure through Dec 2019 was 131472.22% (down 13121021.0% YoY), and the FY2019 annual result was 176430.56%, down 17616855.0% from the prior year.
- EBT Margin climbed to 117588.89% in Q4 2019 per FBRX's latest filing, from 208166.67% in the prior quarter.
- Over five years, EBT Margin peaked at 6.25% in Q3 2018 and troughed at 215711.11% in Q4 2018.
- A 3-year average of 123801.05% and a median of 117588.89% in 2019 frame the typical range for EBT Margin.
- On a YoY basis, EBT Margin climbed as much as 16845556 bps in 2019 and fell as far as 20817292 bps in 2019.
- A 3-year view of EBT Margin shows it stood at 108370.0% in 2017, then tumbled by 99 bps to 215711.11% in 2018, then soared by 45 bps to 117588.89% in 2019.
- Business Quant data shows FBRX's EBT Margin at 117588.89% in Q4 2019, 208166.67% in Q3 2019, and 10311.11% in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -117,588.89% |
| Sep 30, 2019 | -208,166.67% |
| Jun 30, 2019 | -10,311.11% |
| Mar 31, 2019 | -189,822.22% |
| Dec 31, 2018 | -215,711.11% |
| Sep 30, 2018 | 6.25% |
| Jun 30, 2018 | -178,766.67% |
| Mar 31, 2018 | -143,111.11% |
| Dec 31, 2017 | -108,370.00% |
| Sep 30, 2017 | -99,530.00% |
| Jun 30, 2017 | -90,440.00% |